Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) and Pharming Group NV (PHGUF) reported that the release of RUCONEST 50 IU/kg in the U.S. for the treatment of acute angioedema attacks in adult and adolescent patients with hereditary angioedema. Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) stock has highest price of $144.51 in last session, beginning with a price of $143.21 and reported a loss of -1.91% to the closed at $140.45 with a day range of $138.71-$144.51. The stock is going forward its 52-week low with 98.83% and moving down from its 52 week high price with -18.81%.Nymox Pharmaceutical Corporation (NASDAQ:NYMX) reported that the firm's two Phase 3 U.S. studies of NX-1207 for the treatment of BPH, NX02-0017 and NX02-0018, failed to meet their primary efficacy endpoints. Nymox Pharmaceutical Corporation (NASDAQ:NYMX) stock hit highest price at $0.9399, beginning with a price of $0.86 and reported a decrease of -11.80% to the closed at $0.82 with a day range of $0.78-$0.9399. The total market capitalization remained 29.0 Million, total volume of 3.36 Million shares held in the session was surprisingly higher than its average volume of 390.08 shares.Herbalife Ltd. (NYSE:HLF) released that it entered into a settlement contract that, if permitted by the court, will settled a class action court case against the firm. The firm has been aggressively defending itself against the plaintiffs' allegations set forth in Bostick v. Herbalife ever since the lawsuit was filed in 2013. Shares of Herbalife Ltd. (NYSE:HLF) traded at $44.26 by moving down -20.82% with price volatility of 5.50% for a week and 5.96% for a month. Its beta stands at 1.58 times.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
